title: Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells.
abstract: Platelet activating factor (PAF), a potent inflammatory mediator, is implicated in several proinflammatory/inflammatory diseases such as glomerulonephritis, glomerulosclerosis, atherosclerosis, cancer, allergy, and diabetes. PAF can be produced by several renal cells under appropriate stimuli and it is thought to be implicated in renal diseases. The aim of this study is the characterization of DTT-insensitive cholinephosphotransferase (PAF-CPT) of human mesangial cell (HMC), the main regulatory enzyme of PAF de novo biosynthetic pathway. Microsomal fractions of mesangial cells were isolated and enzymatic activity and kinetic parameters were determined by TLC and in vitro biological test in rabbit washed platelets. The effect of bovine serum albumin (BSA), dithiothreitol (DTT), divalent cations (Mg2+ and Ca2+), EDTA, and various chemicals on the activity of PAF-CPT of HMC was also studied. Moreover, preliminary in vitro tests have been performed with several anti-inflammatory factors such as drugs (simvastatin, IFNa, rupatadine, tinzaparin, and salicylic acid) and bioactive compounds of Mediterranean diet (resveratrol and lipids of olive oil, olive pomace, sea bass "Dicentrarchus labrax," and gilthead sea bream "Sparus aurata"). The results indicated that the above compounds can influence PAF-CPT activity of HMC.
authors: Faculty of Chemistry, School of Sciences, National and Kapodistrian University of Athens, Panepistimioupolis, 15771 Athens, Greece.
authors: Alexandros Basilios
authors: AB
authors: Tsoupras
authors: Elizabeth
authors: E
authors: Fragopoulou
authors: Tzortzis
authors: T
authors: Nomikos
authors: Christos
authors: C
authors: Iatrou
authors: Smaragdi
authors: S
authors: Antonopoulou
authors: Constantinos Alexandros
authors: CA
authors: Demopoulos
mesh_terms: D002118:Calcium / Q000494:pharmacology; D002460:Cell Line; D003634:DDT / Q000494:pharmacology*; D002798:Diacylglycerol Cholinephosphotransferase / Q000378:metabolism*; D004229:Dithiothreitol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004492:Edetic Acid / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D004795:Enzyme Stability / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D050527:Mesangial Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D010972:Platelet Activating Factor / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D012969:Sodium Fluoride / Q000494:pharmacology; D013450:Sulfones / Q000494:pharmacology; D013696:Temperature
chemical_list: D010972:Platelet Activating Factor; D013450:Sulfones; D012710:Serum Albumin, Bovine; C002010:4-(2-aminoethyl)benzenesulfonylfluoride; D012969:Sodium Fluoride; D004492:Edetic Acid; D003634:DDT; D002798:Diacylglycerol Cholinephosphotransferase; D002118:Calcium; D004229:Dithiothreitol
references: Scand J Gastroenterol Suppl. 2003;(239):87-93
references: 14743889
references: Biol Reprod. 1997 Feb;56(2):529-36
references: 9116157
references: Drugs. 2004;64(13):1479-502
references: 15212562
references: J Biol Chem. 1979 Oct 10;254(19):9355-8
references: 489536
references: Biochem Biophys Res Commun. 1979 Oct 29;90(4):1194-200
references: 518593
references: C R Seances Acad Sci D. 1979 Nov 26;289(14):1037-40
references: 121258
references: Biochim Biophys Acta. 1981 Feb 23;663(2):545-56
references: 6260215
references: Kidney Int. 1986 Feb;29(2):469-77
references: 3517457
references: Am J Physiol. 1986 Jul;251(1 Pt 2):F1-11
references: 3089026
references: J Biol Chem. 1987 Mar 25;262(9):4215-22
references: 3549727
references: J Biol Chem. 1987 Jul 5;262(19):8990-3
references: 3110152
references: J Neurochem. 1988 Dec;51(6):1755-9
references: 2846783
references: Am J Physiol. 1989 Apr;256(4 Pt 2):F735-41
references: 2705543
references: Drugs. 1991 Aug;42(2):174-204
references: 1717219
references: J Biol Chem. 1991 Nov 15;266(32):21358-61
references: 1657961
references: In Vivo. 1991 Nov-Dec;5(6):589-97
references: 1810444
references: Lipids. 1991 Dec;26(12):1310-5
references: 1819722
references: J Reprod Fertil. 1994 Jul;101(2):385-91
references: 7932373
references: Adv Exp Med Biol. 1996;416:5-10
references: 9131118
references: Biochim Biophys Acta. 1997 Sep 4;1348(1-2):111-6
references: 9370322
references: Kidney Int. 1999 May;55(5):1672-82
references: 10231429
references: J Biol Chem. 1951 Nov;193(1):265-75
references: 14907713
references: Can J Biochem Physiol. 1959 Aug;37(8):911-7
references: 13671378
references: Rev Med Liege. 2004 Dec;59(12):695-703
references: 15658056
references: Mediators Inflamm. 2005 Oct 24;2005(5):263-72
references: 16258193
references: Nutr Rev. 2005 Nov;63(11):374-86
references: 16370222
references: Curr Pharm Des. 2006;12(3):327-40
references: 16454747
references: APMIS. 2006 Feb;114(2):79-102
references: 16519745
references: Nutr Metab Cardiovasc Dis. 2006 Apr;16(3):174-85
references: 16580585
references: Drugs Today (Barc). 2003 Jun;39(6):451-68
references: 12944997
references: Eur J Biochem. 2003 Jul;270(14):2992-3000
references: 12846832
references: Mol Genet Metab. 2002 Nov;77(3):237-48
references: 12409272
references: Neurosci Lett. 2001 Feb 23;299(3):209-12
references: 11165772
references: Annu Rev Biochem. 2000;69:419-45
references: 10966465
references: Neurochem Res. 2000 May;25(5):705-13
references: 10905633
references: Biochem Pharmacol. 2006 May 14;71(10):1479-87
references: 16580641
references: Ann Ital Med Int. 2000 Jan-Mar;15(1):103-7
references: 10842899
references: Int J Biochem. 1994 Sep;26(9):1157-62
references: 7988740
references: Biochim Biophys Acta. 1996 Feb 16;1299(3):353-7
references: 8597590
references: Kidney Int. 1996 Jan;49(1):267-70
references: 8770979
references: Urol Int. 1996;57(1):11-6
references: 8840484
references: Prostaglandins Other Lipid Mediat. 2004 Jan;73(1-2):123-40
references: 15165037